查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
溶瘤病毒免疫治療市場，按產品類型、按應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1408906

溶瘤病毒免疫治療市場，按產品類型、按應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Oncolytic Virus Immunotherapy Market, By Product Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 298 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年溶瘤病毒免疫治療市場規模為1.1億美元，2024年至2032年CAGR為24.5%。

溶瘤病毒免疫治療市場-市場動態

加強合作推動市場需求

預計不斷增加的合作將推動預測期內的市場成長。例如，2022 年 1 月，Siga Technologies 和 Bioarchitech 建立了臨床前合作夥伴關係，研究免疫療法作為癌症治療方法。 TPOXX (tecovirimat) 和 Bioarchitech 的專利「基於痘苗的免疫療法平台」是該研究合作夥伴關係的主題，該平台利用客製化抗體和溶瘤病毒基因組中發現的其他蛋白質。此外，由於IT、網路和人工智慧技術的領導者NEC公司與生物技術公司Transgene簽署了進一步開發合作協議，客製化新抗原癌症疫苗TG4050的臨床評估將在2024年1月繼續進行。設計和開發基於病毒的免疫療法來治療癌症。

溶瘤病毒免疫治療市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 24.5% 左右的CAGR成長
  • 根據應用細分，前列腺癌預計將在預計的時間內以顯著的速度成長
  • 根據最終用戶細分，醫院細分市場預計將在預測期內主導市場
  • 從地區來看，預計北美在預測期內將佔據顯著的市場佔有率

溶瘤病毒免疫治療市場-細分分析：

  • 全球溶瘤病毒免疫治療市場根據產品類型、應用、最終用戶和地區進行細分。
  • 根據產品類型，市場分為基於痘苗病毒的溶瘤病毒、基於水皰性口炎病毒的溶瘤病毒、以HSV為基礎的溶瘤病毒、基於腺病毒的溶瘤病毒和基於新城疫病毒的溶瘤病毒。
  • 根據應用，全球產業分為前列腺癌、膀胱癌、黑色素瘤、卵巢癌、乳癌、肺癌、骨髓瘤等。預計前列腺癌在預計的時間內將以顯著的速度成長。該領域的成長歸因於前列腺癌盛行率的增加。例如，根據次要分析，除皮膚癌外，攝護腺癌是男性最常見的癌症。預計到 2023 年，美國將有 288,300 名男性被診斷出前列腺癌。2020 年，全球預計將有 1,414,259 人被診斷出前列腺癌。它是全球第四常見的癌症。
  • 根據最終用戶，市場分為專科診所、醫院和癌症研究所。預計醫院領域將在預測期內主導市場。在醫院環境中，合格的醫務人員可以在治療期間和治療後密切關注患者，通常會進行溶瘤病毒免疫治療。醫院也經常參與溶瘤病毒免疫治療的臨床研究。在許多癌症類型中，這些研究評估某些治療的安全性和有效性。

溶瘤病毒免疫治療市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美在預測期內將佔據顯著的市場佔有率，因為與其他國家相比，患者數量正在成長。由於美國癌症發生率的上升，該市場正在擴大。根據美國癌症協會的 2021 年報告，2021 年美國有 608,570 人死於癌症，同時預計將發現 190 萬新癌症病例。促進市場成長的其他原因包括對不同癌症療法的了解增加、該地區複雜的免疫腫瘤藥物的可用性以及美國等國家不斷擴大的醫療保健支出。美國醫療保險和醫療補助服務中心（CMS）發布的資料顯示，2020年美國醫療保健支出成長9.7%，達到4.1兆美元，即每人12,530美元。醫療支出佔該國GDP的19.7%。從而推動該地區的市場擴張。

溶瘤病毒免疫療法市場-競爭格局：

市場上的主要參與者有： Amgen, Inc.、Sorrento Therapeutics Inc.、Merck & Co., Inc.、Oncolytics Biotech, Inc.、Viralytics Ltd.、上海3D生物科技有限公司、SillaJen, Inc.。 、RIGVIR Ltd.、ORYX GmbH & Co. KG、Cold Genesys, Inc. 和Transgene Biotek Ltd.。這些參與者採取了各種策略來維持市場競爭力，包括產品發布、收購、合作、協議等。

最近的發展：

2022 年 7 月，專注於基因和癌症療法、候選疫苗和其他應用的病毒的創建和生產的純粹合約開發和製造組織 (CDMO) ABL 宣布與私營生物技術企業 KaliVir 免疫治療公司合作創建最先進的下一代溶瘤病毒免疫治療計劃。對於即將進行的臨床研究，ABL 將生產 KaliVir 開發的溶瘤病毒。

目錄

第1章：溶瘤病毒免疫治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的溶瘤病毒免疫療法市場片段
    • 溶瘤病毒免疫療法市場片段（依應用）
    • 最終用戶的溶瘤病毒免疫治療市場片段
    • 按國家/地區分類的溶瘤病毒免疫療法市場片段
    • 按地區分類的溶瘤病毒免疫治療市場片段
  • 競爭洞察

第 3 章：溶瘤病毒免疫療法主要市場趨勢

  • 溶瘤病毒免疫治療市場促進因素
    • 市場促進因素的影響分析
  • 溶瘤病毒免疫治療市場限制
    • 市場限制影響分析
  • 溶瘤病毒免疫治療市場機會
  • 溶瘤病毒免疫治療市場未來趨勢

第 4 章：溶瘤病毒免疫治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：溶瘤病毒免疫治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：溶瘤病毒免疫治療市場格局

  • 2023 年溶瘤病毒免疫治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：溶瘤病毒免疫治療市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 基於痘苗病毒的溶瘤病毒
    • 基於水泡性口炎病毒的溶瘤病毒
    • 基於 HSV 的溶瘤病毒
    • 基於腺病毒的溶瘤病毒
    • 基於新城疫病毒的溶瘤病毒

第 8 章：溶瘤病毒免疫治療市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 攝護腺癌
    • 膀胱癌
    • 黑色素瘤
    • 卵巢癌
    • 乳癌
    • 肺癌
    • 骨髓瘤
    • 其他

第 9 章：溶瘤病毒免疫治療市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 專科診所
    • 醫院
    • 癌症研究機構

第 10 章：溶瘤病毒免疫治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美溶瘤病毒免疫療法主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲溶瘤病毒免疫療法主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區溶瘤病毒免疫療法主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲溶瘤病毒免疫療法主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲溶瘤病毒免疫療法主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析-溶瘤病毒免疫治療產業

  • 競爭儀表板
  • 公司簡介
    • Amgen, Inc.
    • Sorrento Therapeutics Inc.
    • Merck & Co., Inc.
    • Oncolytics Biotech, Inc.
    • Viralytics Ltd.
    • Shanghai Sunway Biotech Co., Ltd.
    • SillaJen, Inc.
    • RIGVIR Ltd.
    • ORYX GmbH & Co. KG
    • Cold Genesys, Inc.
    • Transgene Biotek Ltd.

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2075

REPORT HIGHLIGHT

Oncolytic Virus Immunotherapy Market size was valued at USD 110 Million in 2023, expanding at a CAGR of 24.5% from 2024 to 2032.

The oncolytic viral immunotherapy includes the use of viruses to infect and then kill cells with cancer. It is well-recognized that cancer cells have weakened antiviral defenses, leaving them more vulnerable to infections than healthy body cells. Oncolytic viruses are designed to deliver therapeutic payloads to tumor cells while exhibiting a reduced capacity to infect healthy cells.

Oncolytic Virus Immunotherapy Market- Market Dynamics

Increasing collaboration to propel market demand

The increasing collaboration is expected to propel the market growth during the forecast period. For instance, in January 2022, Siga Technologies and Bioarchitech formed a preclinical partnership to study immunotherapy as a cancer treatment. The TPOXX (tecovirimat) and Bioarchitech's patented "vaccinia-based immunotherapy platform," which makes use of tailored antibodies and other proteins found in the oncolytic virus's genome, are the subjects of the research partnership. Moreover, in January 2024, the clinical evaluation of the customized neoantigen cancer vaccine TG4050 will continue due to the signing of a further development collaboration agreement by NEC Corporation, a leader in IT, network, and AI technologies, and Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer.

Oncolytic Virus Immunotherapy Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 24.5% over the forecast period (2024-2032)
  • Based on application segmentation, prostate cancer is expected to grow at a significant rate over the projected timeframe
  • Based on end-user segmentation, the hospitals segment is expected to dominate the market during the forecast period
  • Based on region, North America is expected to hold a prominent market share during the forecast period

Oncolytic Virus Immunotherapy Market- Segmentation Analysis:

  • The Global Oncolytic Virus Immunotherapy Market is segmented based on Product Type, Application, End-User, and Region.
  • Based on the product type, the market is bifurcated into Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, HSV-based Oncolytic Viruses, Adenovirus-based Oncolytic Viruses and Newcastle Disease Virus-based Oncolytic Viruses.
  • Based on the application, the global industry is segmented into Prostate Cancer, Bladder Cancer, Melanoma, Ovarian Cancer, Breast Cancer, Lung Cancer, Myeloma and Others. Prostate cancer is expected to grow at a significant rate over the projected timeframe. The growth in the segment is attributed to the increasing prevalence of prostate cancer. For instance, according to secondary analysis, except for skin cancer, prostate cancer is the most frequent cancer among males. An estimated 288,300 males in the US will receive a prostate cancer diagnosis in 2023. In 2020, a projected 1,414,259 individuals received a prostate cancer diagnosis worldwide. It ranks as the fourth most prevalent kind of cancer worldwide.
  • Based on the end-user, the market is divided into Specialty Clinics, Hospitals and Cancer Research Institutes. The hospital segment is expected to dominate the market during the forecast period. In a hospital setting, where qualified medical staff can keep an eye on patients both during and after treatment, oncolytic viral immunotherapy is usually given. Hospitals are also frequently participating in oncolytic virus immunotherapy clinical studies. In many cancer types, these studies evaluate the safety and effectiveness of certain treatments.

Oncolytic Virus Immunotherapy Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold a prominent market share during the forecast period because the number of patients is growing in comparison to other nations. The market is expanding as a result of the United States' increased cancer incidence rates. According to the American Cancer Society's 2021 report, 608,570 people died from cancer in the US in 2021, while an anticipated 1.9 million new cases of cancer were identified. The other reasons that contribute to the growth of the market include increased knowledge about different cancer therapies, the availability of sophisticated immune-oncology medications in the area, and the expanding healthcare spending in countries such as the United States. The Centers for Medicare and Medicaid Services (CMS) released data showing that U.S. healthcare spending increased by 9.7% in 2020 to reach USD 4.1 trillion, or USD 12,530 per person. Health spending made up 19.7 percent of the country's GDP. Thus, driving the market expansion in the region.

Oncolytic Virus Immunotherapy Market- Competitive Landscape:

The key players operating in the market are: Amgen, Inc., Sorrento Therapeutics Inc., Merck & Co., Inc., Oncolytics Biotech, Inc., Viralytics Ltd., Shanghai Sunway Biotech Co., Ltd., SillaJen, Inc., RIGVIR Ltd., ORYX GmbH & Co. KG, Cold Genesys, Inc. and Transgene Biotek Ltd. These players adopted various strategies to remain competitive in the market which include, product launches, acquisitions, collaboration, agreements and others.

Recent Developments:

In July 2022, ABL, a pure play Contract Development and Manufacturing Organization (CDMO) focused on the creation and production of viruses for gene and cancer therapies, vaccine candidates, and other applications, announced its collaboration with KaliVir Immunotherapeutics, a privately held biotech business creating state-of-the-art, next-generation oncolytic viral immunotherapy programs. For the impending clinical study, ABL will produce the oncolytic viruses developed by KaliVir.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amgen, Inc.
  • Sorrento Therapeutics Inc.
  • Merck & Co., Inc.
  • Oncolytics Biotech, Inc.
  • Viralytics Ltd.
  • Shanghai Sunway Biotech Co., Ltd.
  • SillaJen, Inc.
  • RIGVIR Ltd.
  • ORYX GmbH & Co. KG
  • Cold Genesys, Inc.
  • Transgene Biotek Ltd.

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vaccinia Virus-based Oncolytic Viruses
  • Vesicular Stomatitis Virus-based Oncolytic Viruses
  • HSV-based Oncolytic Viruses
  • Adenovirus-based Oncolytic Viruses
  • Newcastle Disease Virus-based Oncolytic Viruses

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Prostate Cancer
  • Bladder Cancer
  • Melanoma
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Myeloma
  • Others

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Specialty Clinics
  • Hospitals
  • Cancer Research Institutes

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Oncolytic Virus Immunotherapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Oncolytic Virus Immunotherapy Market Snippet by Product Type
    • 2.1.2. Oncolytic Virus Immunotherapy Market Snippet by Application
    • 2.1.3. Oncolytic Virus Immunotherapy Market Snippet by End-User
    • 2.1.4. Oncolytic Virus Immunotherapy Market Snippet by Country
    • 2.1.5. Oncolytic Virus Immunotherapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Oncolytic Virus Immunotherapy Key Market Trends

  • 3.1. Oncolytic Virus Immunotherapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Oncolytic Virus Immunotherapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Oncolytic Virus Immunotherapy Market Opportunities
  • 3.4. Oncolytic Virus Immunotherapy Market Future Trends

4. Oncolytic Virus Immunotherapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Oncolytic Virus Immunotherapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Oncolytic Virus Immunotherapy Market Landscape

  • 6.1. Oncolytic Virus Immunotherapy Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Oncolytic Virus Immunotherapy Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Vaccinia Virus-based Oncolytic Viruses
    • 7.1.3. Vesicular Stomatitis Virus-based Oncolytic Viruses
    • 7.1.4. HSV-based Oncolytic Viruses
    • 7.1.5. Adenovirus-based Oncolytic Viruses
    • 7.1.6. Newcastle Disease Virus-based Oncolytic Viruses

8. Oncolytic Virus Immunotherapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Prostate Cancer
    • 8.1.3. Bladder Cancer
    • 8.1.4. Melanoma
    • 8.1.5. Ovarian Cancer
    • 8.1.6. Breast Cancer
    • 8.1.7. Lung Cancer
    • 8.1.8. Myeloma
    • 8.1.9. Others

9. Oncolytic Virus Immunotherapy Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Specialty Clinics
    • 9.1.3. Hospitals
    • 9.1.4. Cancer Research Institutes

10. Oncolytic Virus Immunotherapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Oncolytic Virus Immunotherapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Oncolytic Virus Immunotherapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Oncolytic Virus Immunotherapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Oncolytic Virus Immunotherapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Oncolytic Virus Immunotherapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Oncolytic Virus Immunotherapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Amgen, Inc.
    • 11.2.2. Sorrento Therapeutics Inc.
    • 11.2.3. Merck & Co., Inc.
    • 11.2.4. Oncolytics Biotech, Inc.
    • 11.2.5. Viralytics Ltd.
    • 11.2.6. Shanghai Sunway Biotech Co., Ltd.
    • 11.2.7. SillaJen, Inc.
    • 11.2.8. RIGVIR Ltd.
    • 11.2.9. ORYX GmbH & Co. KG
    • 11.2.10. Cold Genesys, Inc.
    • 11.2.11. Transgene Biotek Ltd.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Oncolytic Virus Immunotherapy Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Oncolytic Virus Immunotherapy Market, by Product Type 2019-2032 (USD Million)
  • TABLE Oncolytic Virus Immunotherapy Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Oncolytic Virus Immunotherapy Market, by Application 2019-2032 (USD Million)
  • TABLE Oncolytic Virus Immunotherapy Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Oncolytic Virus Immunotherapy Market, by End-User 2019-2032 (USD Million)
  • TABLE Oncolytic Virus Immunotherapy Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Oncolytic Virus Immunotherapy Market, by Region 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Oncolytic Virus Immunotherapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Europe Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Asia Pacific Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Latin America Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Middle East and Africa Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE Germany Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE India Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE Brazil Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE Saudi Arabia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)